The Foundation of Sarcoidosis Research (FSR) maintains a strong Scientific Advisory Board (SAB) composed of world renowned key opinion leaders within the fields of sarcoidosis, medical research, therapy development, and medical practice. The SAB helps advance FSR towards its mission dedicated to finding a cure for this disease and to improving care for sarcoidosis patients.
Elliott Crouser, MD
SAB Chair
Ohio State University
Robert Baughman, MD
John Belperio, MD
UCLA Medical Center
Edward Chen, MD
Johns Hopkins University
Ulrich Costabel, MD, FERS
University of Duisburg-Essen
Wonder Drake, MD
Vanderbilt University
Marjolein Drent, MD, PhD
St. Antonius Hospital
Andrew Fontenot, MD
University of Colorado
Skip Garcia, MD
University of Arizona
Ennis James, MD
Medical University of South Carolina
Craig Lipset
Managing Partner
Clinical Innovation Partners
Lisa Maier, MD, MSPH, FCCP
National Jewish Health
Adam Morgenthau, MD
Icahn School of Medicine at Mount Sinai
Ogugua Obi, MD, MPH, MSc
East Carolina University
Misha Rosenbach, MD
University of Pennsylvania
Milton Rossman, MD
University of Pennsylvania
Barney Stern, MD
University of Maryland
Dominique Valeyre, MD
Hôpital Avicenne
Please note: While FSR receives guidance and input from our Scientific Advisory Board (SAB), it is not to be implied that all SAB members support or are in agreement in each specific FSR initiative or approach. As with most professional groups, members may have differing perspectives and opinions on various issues. FSR’s intent is always to work toward consensus with our experts as much as feasible while addressing patient and research needs.